The SHANK2 tumor suppressor is frequently disrupted by structural variants8, TERT activating alterations frequently occur in high-risk neuroblastoma9, and ATRX inactivation occurs in a large proportion of adolescent and young adult neuroblastomas but rarely in those arising from younger patients10. The gene discussed is ATRX; the disease is neuroblastoma.